| 1KEN | date | ![]() |
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||||||
| compound | source | ||||||||||||||||||
| symmetry |
| ||||||||||||||||||
| crystal cell |
| ||||||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||||||
| ligand | MAN, NAG | enzyme |
| ||||||||||||||||
| Gene Ontology |
| ||||||||||||||||||
| Primary reference | An antibody that prevents the hemagglutinin low pH fusogenic transition., Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M, Virology 2002 Mar 1;294(1):70-4. PMID:11886266 | ||||||||||||||||||
| Data retrieval |
![]() |
| View 1KEN in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |